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Inhaled corticosteroids have been shown to reduce morbidity and the need for hospitalization from 
asthma. Despite improvements in the therapy of asthma, epidemiologic data from several countries has 
shown that the hospital admission rates for asthma among adults at a population level are on the 
increase. The prevalence rate of hospital admission for asthma among Maltese adults aged 15-59 years 
was determined retrospectively from 1989 to 1993. Concurrent yearly total dispensal of inhaled 
corticosteroids for the whole population was also calculated. This study was undertaken amongst a 
well-defined island population served by a single medical facility offering emergency services, and a 
possible association between these two trends was investigated by means of logistic regression, The 
age-specific hospital admission rates for asthma decreased from 96.2 (95% CI: 109.7, 82.7) per 100 000 
in 1989 to 38.1 (95% CI: 46.4, 29.8) per 100 000 in 1993. The prevalence rates of admission from asthma 
decreased from 67.6 (95% CI: 78.9, 56.3) per 100 000 in 1989 to 30.6 (95% CI: 38.0, 23.2) per 100 000 in 
1993. The dispensal of inhaled beclomethasone dipropionate (BDP) increased from 0.99 defined daily 
dose (DDD) per 1000 population in 1989 to 3.28 DDD per 1000 in 1993. Logistic regression showed that 
increasing dispensal of inhaled BDP by 1 DDD per 1000 decreased the odds of an admission from 
asthma to 0.71 (95% CI: 0.65, 0.78) times their previous value. Similarly, the odds of an individual being 
hospitalized because of asthma decreased to 0.75 (95% CI: 0.67, 0.83) times their previous value. This 
study concludes that there was a progressive decrease in hospital admission rates for asthma in adults, 
and this trend correlates well with increasing use of inhaled corticosteroids at a community level. This 
must, however, be interpreted with care in light of the fact that increase in utilization of anti- 
inflammatory therapy probably also reflected improved general and widespread care for asthma. 
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Introduction 
The aim of asthma management in adults is to 
achieve control of symptoms and to maintain the best 
possible quality of life. Recently updated guidelines 
(1) suggest methods through which these goals may 
be reached. 
The prevention of exacerbation of asthma is a 
principal goal of management, and admission to 
hospital is often an extreme consequence of deterio- 
rating control. Indeed, one of the indicators of 
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asthma control at a population level is the need for 
hospital admission. 
Inhaled corticosteroids are, at present, the most 
effective anti-inflammatory therapy available to con- 
trol asthma in patients of all ages. A number of 
prospective clinical trials have shown that they 
improve lung function, suppress symptoms and 
reduce the number of exacerbations (2,3). The first 
available inhaled costicorteroid was beclomethasone 
dipropionate (BDP) (4), and, at present, the use of 
high-dose inhaled steroids seems to achieve better 
control in those individuals with more severe and 
unstable asthma (5). 
Two recent reviews of the epidemiology of asthma 
suggest that hospital admission rates of adult patients 
from asthma appear to be on the increase (6,7). On 
the other hand, a recent study has documented a 
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progressive decrease in hospital admission rates from 
asthma; this was found to be concurrent with the 
increased consumption of an inhaled corticosteroid 
(8). 
The aim of this .5-yr retrospective study was to 
study whether the change in hospital admission rates 
for acute severe asthma among adult patients corre- 
lated in any way with a change in dispensal rate of 
inhaled corticosteroids in the entire population of an 
island. 
Methods 
This study was conducted on the island of Malta. The 
total population at the end of 1993 stood at 339 173, 
with a density of 1380 km - *. The island has a typical 
Mediterranean climate with mild winters and hot 
summers. All adults permanently residing in Malta 
have a unique identification number, which is also 
used for administrative purposes within the health- 
care system. 
The State health-care system is free of charge and 
easily accessible to all. Locally-based health centres 
and family physicians provide primary care. St. 
Luke’s Hospital, a centrally-located teaching hospi- 
tal, is the only facility on the island where acute 
medical care at all levels was provided over the study 
period. The total number of medical admissions for 
patients over 14 years of age was 38.3 per 1000 for 
1989 and 40.6 per 1000 for 1993. Ttie maximum 
possible distance from the hospital is only 19 km. 
Data on the population was obtained from the 
Central Office of Statistics of Malta (9). A population- 
based study of asthma in Malta investigated the 
epidemiology of this condition in school children. 
A total birth cohort of 8-year-olds was screened in 
1985, and the cumulative prevalence was found to be 
8.1% (10). 
STUDY POPULATION 
The individuals studied were adults between the ages 
of 15 and 59 years of age. Individuals aged 60 years 
and over were excluded from the study in order to 
minimize the effect of chronic obstructive airways 
disease as a possible confounding factor. All patients 
suffering from acute asthma and presenting to hospi- 
tal are seen by casualty department medical officers. 
The decision to admit a patient is always taken by a 
more senior physician and recorded on a specific 
register. 
A team of four doctors manually examined regis- 
ters documenting medical admissions between 1 
January 1989 and 3 1 December 1993. Cases where 
asthma was not the main reason for admission, or 
when it was unclear whether the presenting problems 
were due to bronchitis or acute asthma, were not 
included. Another exclusion criterion was residence 
status; Malta being a tourist destination, temporary 
visitors were not considered for the purposes of this 
study. Concomitant information using the same 
exclusion criteria was collected regarding admissions 
to the intensive care unit. 
As individual data were available for each patient, 
one could measure yearly individual events and age- 
specific yearly patient prevalence rates. In every 
instance, age in years was obtained by subtracting the 
year of birth from the year of admission. The Health 
Information Systems Unit, a State organization, pro- 
vided information about admissions for all medical 
cases. The latter organization also provided informa- 
tion about deaths from asthma for the whole Maltese 
population. 
TREATMENT 
All individuals suffering from asthma are entitled to 
free medication for treatment of this condition. Medi- 
cation is dispensed from Health Service Pharmacies, 
where no prescription fees are charged. Patients may 
opt to purchase medication from privately-owned 
pharmacies. Beclomethasone dipropionate (in 50 and 
250 lug dose per metered inhalation) is by far the most 
widely prescribed inhaled steroid, and over the years 
studied, use of budesonide was negligible. All BDP is 
imported into the island and, therefore, complete 
data about dispensed BDP could be obtained from 
the only two primary sources. The Pharmacy Unit 
within the State Department of Health provided 
information about free-of-charge medication, and the 
local importing agency provided data about BDP 
dispensed privately. The amount of BDP (5Opg per 
inhalation) dispensed to control allergic rhinitis was 
not taken into account; this was possible as this form 
of steroid is marketed in Malta under a different 
brand name. 
Dispensal of inhaled steroids is expressed in defined 
daily dose (DDD) per 1000 inhabitants. One DDD 
for BDP is 800 pug day - ‘, DDD being the assumed 
average maintenance dose of this medication per 
day in adults (11,12). The amount of inhaled BDP 
dispensed in 1 yr was calculated according to the 
following formula: 
amount of drug sold in 1 yr (mg) 
DDD x 365 x number of inhabitants 
x 1000 inhabitants 
Preparations combining steroids and p-agonists for 
inhalation were not prescribed. The long-acting 
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,&agonist salmeterol was introduced at the end of 
1992 and, by the end of 1993, only around 10 patients 
were receiving this form of treatment in the whole of 
Malta. 
STATISTICAL ANALYSIS 
The time trend of hospital admission from asthma 
was studied by linear regression. The relationship 
between admission to hospital from asthma and use 
of inhaled steroids at a population level over a 5-yr 
period was analysed statistically by means of logistic 
regression. The equation for this relationship is given 
by: 
log, (y/T-y)=a+/LX (1) 
The left-hand side of Equation 1 is the natural 
logarithm of the odds of an asthma admission; y 
relates to number of either events or individuals 
hospitalized for asthma between the ages of 15 and 59 
years, and T is the total population between the ages 
of 15 and 59 years. The yearly dispensal of inhaled 
BDP in DDD per 1000 population is represented by 
X, while a and p are constants. a represents the 
intercept, and /I represents the slope of the regression 
model. 
Results 
In the island of Malta, over the study period 1989993, 
the yearly asthma hospitalization rate for adults 
decreased. The yearly prevalence rate of hospital 
admissions from asthma for persons between the 
ages of 15 and 59 years decreased from 96.2 [95X 
Confidence Interval (CI): 109.7, 82.71 per 100 000 in 
1989 to 38.1 (95%) CI: 46.4, 29.8) per 100 000 in 1993. 
The prevalence rates of admission from asthma 
decreased from 67.6 (95% CI: 78.9, 56.3) per 100 000 
in 1989 to 30.6 (95% CI: 38.0, 23.2) per 100 000 in 
1993 (Fig. 1). Although, concurrently, the study 
population increased by 4.9% (Table l), the drift 
between lo-yr age groups over the study period was 
negligible. 
Between 1989 and 1993, the total amount of 
inhaled steroids dispensed rose progressively. The 
dispersal of inhaled BDP increased from 0.99 DDD 
per 1000 population in 1989 to 3.28 DDD per 1000 in 
1993 (Table 2). Beclomethasone dipropionate, 50 pg 
per metered dose, was the predominant form pre- 
scribed, and use of this form of medication increased 
every year between 1989 and 1992. In 1993, there was 
a decline in use of BDP 50 pg per dose, in contrast to 
the sharp rise in the use of BDP 250,ug per dose 
during that year. 
I 
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Year 
FIG. 1. Prevalence rate of hospitalization from 
asthma: adults aged 15-59 years in Malta. 
(v= - 0.983, PcO.01) Symbols represent observed 
rates; predicted trend based on linear regression, 
Horizontal bars represent 95% confidence intervals 
for prevalence estimates. 
The association between decrease in hospital 
admission from asthma and the concomitant increase 
in consumption of inhaled steroids was studied by 
means of logistic regression analysis (Fig. 2, Table 3). 
The logistic model is valid, as the plot of the loga- 
rithm of the odds of hospital admission can be 
approximated well by a straight line; this holds both 
for events and individuals. 
The exponential of the slopes shows that increasing 
the dispensal of inhaled BDP by 1 DDD per 1000 
population decreased the odds of an admission from 
asthma to 0.71 (95% CI: 0.65, 0.78) times their 
previous value. Similarly, the odds of an individual 
being hospitalized because of asthma decreased 
to 0.75 (95% CI: 0.67, 0.83) times their previous 
value. 
Discussion 
Asthma control in a particular community depends 
on many factors, foremost amongst them the avail- 
ability, accessibility and quality of health care at 
primary level. At a subsequent level of care, hospital 
admissions are often not only dictated by need, on 
the basis of the clinical picture, but also by factors 
such as availability of beds and the practice style 
of physicians determining admissions (13). Recent 
reports suggest that the number of hospital admis- 
sions and the amount of outpatient care required to 
treat asthma are on the increase, even if deaths from 
asthma are decreasing (6,14). 
414 J.M.CACCIOTTOLO ET AL. 
TABLE 1. Hospital admissions and deaths from acute asthma in adults aged 15-59 years in Malta 
Admissions 
Year Total Patients ICU Deaths Population Admission rate* Prevalence rate* 
1989 195 137 11 6 202 676 96.2 (109.7-82.7)t 67.6 (78.9-56.3) 
1990 157 107 8 1 205 157 76.5 (88.5-64.5) 52.2 (62.142.3) 
1991 147 97 6 2 207 845 70.7 (82.1-59.3) 46.7 (57.0-35.4) 
1992 116 84 4 2 210 103 55.2 (65.345.1) 40.0 (48.5-3 1.5) 
1993 81 65 6 3 --212 609 38.1 (46.429.8) 30.6 (38.0-23.2) 
*Per 100 000 population, tparentheses represent 95% confidence interval; ICU, intensive-care unit. 
TABLE 2. Yearly dispensal of inhaled beclomethasone dipropionate in Malta 
50 ,ug dose - ’ 25opg-’ Total 
Year g DDD g DDD g DDD 
1989 97.3 0.94 5.10 0.05 102.40 0.99 
1990 119.72 1.18 6.50 0.06 126.22 1.24 
1991 180.52 1.72 13.00 0.12 193.52 1.84 
1992 236.69 2.23 57.95 0.55 294.64 2.78 
1993 230.54 2.15 120.95 1.13 351.49 3,28 
DDD, Defined daily doses per 1000 population. 
The present paper reports a steady and statistically 
significant downward trend in hospital admission 
rates of adults from asthma at a population level. 
This decrease happened despite an increase in total 
adult medical admissions and an increase in the adult 
study population. Both admissions from asthma to 
the only intensive-care unit serving the population, 
and deaths from asthma (inside and outside hospital) 
also seemed to decrease over the 5-yr study period. 
Numbers were, however, too small for statistical 
analysis. 
The present study was greatly facilitated by several 
important factors. Principal among them were a 
well-defined stable island population with negligible 
migration rates, proximity of easily available health 
services, and one central university hospital offering 
emergency facilities. These conditions ensured accu- 
racy of the denominator population, and that all 
episodes of acute asthma needing hospital admission 
could be identified. Furthermore, neither cost of 
medication, nor cost of hospital admission were 
determining factors, as both were free of charge to all 
individuals in the population studied. The health-care 
system remained virtually unchanged during the 
study period. There were no administrative changes 
-8.1 - 
-8.3’ “/“I ““‘I ““‘/ ‘I ” ’ ” 
0.8 1.3 1.8 2.3 2.8 3.3 
Defined daily doses per 1000 population 
FIG. 2. Odds ratio of admission from asthma corre- 
lated with dispensal of inhaled beclomethasone 
dipropionate in Malta. +, events; a= - 6.66, 
b= - 0.34, Y= - 0.967, r,=0.935, PcO.01. n , indi- 
viduals; a= - 7.09, b= - 0.29, r= - 0.961, r2 =0*922, 
PcO.01. +, events; n , individuals. 
in the running of acute emergency services, and no 
financial disincentive was applied during this period. 
Furthermore, as proximity and availability of services 
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TABLE 3. Logistic regression of odds of hospital admission for asthma per year against 
yearly dispensal of inhaled beclomethasone dipropionate: Malta, 1989-93 
Coefficient/ Exponential 95% confidence interval 
Term Coefficient SE SE (coefficient) exponential (coefficient) 
Events 
P - 0.34 0.046 7.4 0.71 0.65 0.78 
a - 6.66 0.09 1 73.4 1.29 x 1O-3 1.08 x 1O-3 1.54 x lo-’ 
Individuals 
P - 0.29 0.054 5.41 0.75 0.67 0.83 
a - 7.09 0.108 65.4 8.31 x 1O-4 6.71 x 1O-4 1.03 x 10-s 
Log, (y/T - y) = a +/Ix; x, defined daily doses for inhaled beclomethasone dipropionate per 
1000 population; y, number of events or individuals per year; T, total population. 
also remained unchanged, it was reasonable to 
assume that there were no significant changes in 
admission criteria. 
There are several reasons for the decline in hospital 
admission rates from asthma, and some are probably 
unquantifiable at a population level. The principal 
reason is probably improved and consistent asthma 
care at a primary level in the community. This 
involves not only better patient monitoring and edu- 
cation, but also increased appreciation by family 
physicians of the role of prophylaxis possible through 
more widespread and earlier use of anti-inflammatory 
medication. 
Concurrent with the decline in adult hospital 
admission rates from asthma, this paper reports a 
steady increase in the use of inhaled corticosteroids at 
a population level. The unit of quantity DDD was 
used as a measure of drug consumption; it is a useful 
epidemiological tool, but not a therapeutic recom- 
mendation. This measure is, however, close to pre- 
scribing reality (12). It is accepted that inhaled 
corticosteroids are prescribed almost exclusively for 
prophylaxis of asthma and there is no specific indica- 
tion for this form of medication other than asthma. 
The possible relationship between &agonist use in 
asthma and change in hospitalization rates was not 
studied at a population level, as the latter medications 
are also widely used by patients suffering from 
chronic obstructive pulmonary disease. 
The BDP 250,ug dose represented a progressively 
higher proportion of the total BDP dispensed. This 
probably reflected the increasing tendency to replace 
the BDP 5Opg dose formulation with the higher 
potency formulation in those patients with more 
severe asthma, in line with recent recommendations. 
The data that is presented on dispensed inhaled 
steroids refers to a whole population without reserva- 
tions. At this level, it is very difficult to determine the 
amount of inhaled steroids actually consumed effec- 
tively by a specific age group of the population. One 
has to assume that use of inhaled corticosteroids by 
the segment of the population aged between 15 and 
59 years is reflected to a large extent by prescribing 
trends in the whole population. 
Use of inhaled steroids has been shown to decrease 
the mean number of hospital admissions amongst 
patients suffering from chronic steroid-dependent 
asthma (15). Even in mild asthma, early treatment 
with an inhaled steroid results in long-lasting control 
(16). The risk of fatal and non-fatal asthma in 
patients who had been dispensed one or more BDP 
metered-dose inhalers monthly was significantly 
reduced (17). On a larger scale, a Swedish study 
found significant correlation between increased use of 
inhaled steroids and reduction in hospital admission, 
irrespective of whether the latter was measured 
through bed days or discharges (8). 
In conclusion, this study has documented a pro- 
gressive decrease in hospital admission rates for 
asthma in a well-defined community. This trend 
correlated well with increasing use of inhaled corti- 
costeroids in the population. However, this must be 
carefully interpreted in light of the fact that increase 
in utilization of anti-inflammatory therapy probably 
also reflected improved general and widespread care 
for asthma. 
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